BioSpace News Archive

Pharm Country

J&J to Spend More on R&D With Tax Reform Money

But for now, the world’s biggest healthcare company isn’t providing many details on how it may use the extra money from lower tax rates.

January 24, 2018
·
1 min read
Deals

5 Biotechs Drawing Buyout Buzz in 2018

Here are five possible acquisition targets to keep an eye on.

January 24, 2018
·
4 min read
·
Mark Terry
Pharm Country

Why This Connecticut Biotech Could be a $1M Opportunity for Investors

Could Cara be the answer for investors itching to make $1 million?

January 24, 2018
·
2 min read
·
Mark Terry
Deals

Chinese Tycoon Eyes $500M IPO of Luye Life Sciences’ Clinic Arm

The company’s Luye Medical Group unit plans to evaluate proposals from investment banks as soon as next month, according to the people.

January 24, 2018
·
1 min read
Business

Why This Heart Drug Could Be a $5B Blockbuster for Novartis

Entresto, introduced in 2015, got off to a slow start but brought in $507 million in revenue last year.

January 24, 2018
·
1 min read
Deals

Flushed With Cash, Shanghai Pharma Hunts for M&A in the U.S. and Europe

This acquisition strategy is part of its two-pronged approach to growth, along with internal R&D.

January 24, 2018
·
2 min read
·
Mark Terry
Business

TxCell Announces 4th Quarter 2017 Financials and Participation at Upcoming Scientific Conferences

TxCell today reports its fourth quarter 2017 financials and provides an update on its financing.

January 24, 2018
·
6 min read
Business

Novartis Poised for Growth as CEO Hands Baton to Successor

Narasimhan takes over the role of CEO in February as current CEO Joe Jimenez retires.

January 24, 2018
·
3 min read
·
Alex Keown
Deals

How High Novo Nordisk Could and Should Go for Ablynx

Novo has tried to apply pressure, but the ABLX board and principal shareholder have not been moved.

January 24, 2018
·
1 min read
Gecko Biomedical Secures €6 Million in Funding under the Investments for the Future Programme (Programme d’investissements d’avenir, PIA), to Industrialize and Develop Innovative Solutions for Tissue Reconstruction

This funding is a contribution towards the industrialization and development of innovative solutions in the area of tissue reconstruction, and the peripheral nerve in particular.

January 24, 2018
·
6 min read